Walgreens plans to expand its specialty pharmacy services and invest in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners.
Cardinal Health announced that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. Expectations are that McKesson will be receive the new contracts
Celltrion Healthcare recently signed an agreement with Libertyville, IL-based CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the U.S. market
The FTC is expanding its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs
Combined with a number of recent acquisitions and ongoing consolidation by market participants, we view the primary care market undergoing a major transformation over the next few years.
The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry.
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution